欢迎您加入月均活跃用户100万＋的科研社区！如您有任何系统建议，请；如有合作推广需求，请点此洽谈。
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | LANCET ONCOLOGY LANCET ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.8
51人评分
我要评分
声誉 10.0 影响力 9.7 速度 9.3 | |||||||||||||||||||||
| 期刊ISSN | 1470-2045 | 
蝌蝌APP，让您与同行交流更轻松
 立即下载 | ||||||||||||||||||||
| E-ISSN | 1474-5488 | |||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 35.9 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2025年5月19日：35.546 | |||||||||||||||||||||
| 2024-2025自引率 | 1.70%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 42 | |||||||||||||||||||||
| JCI期刊引文指标 | 8.68 | |||||||||||||||||||||
| h-index | 274 | |||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://www.thelancet.com/journals/lanonc/issue/current | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/THELANCETONCOLOGY | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足LANCET ONCOLOGY的语言要求，还能让LANCET ONCOLOGY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被LANCET ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710 | |||||||||||||||||||||
| 出版商 | Lancet Publishing Group | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 2000 | |||||||||||||||||||||
| 年文章数 | 168点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 11.62% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 83.33% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中国科学院期刊分区 （ 2025年3月最新升级版） | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||
| 中国科学院期刊分区 （ 2023年12月升级版） |
| |||||||||||||||||||||
| 中国科学院期刊分区 （ 2022年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1470-2045%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-8周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 极难 | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在LANCET ONCOLOGY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial Author: Zhou, Jian; Bai, Li; Luo, Jia; Bai, Yuxian; Pan, Yaozhen; Yang, Xinrong; Gao, Yufeng; Shi, Rongshu; Zhang, Wenhua; Zheng, Jinfang; Hua, Xiangdong; Xu, Aibing; Hu, Sheng; Zhang, Feng; Yang, Xiaojun; Da, Mingxu; Wang, Rui; Ma, Jie; Jia, Weidong; Quan, Dongmei; Peng, Chuang; Yang, Wei; Yin, Guowen; Qi, Yue; Zhang, Guifang; Du, Xilin; Mao, Xiaorong; Meng, Zhiqiang; Jiao, Shunchang; Fan, Jia Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 6, pp. 719-731. DOI: 10.1016/S1470-2045(25)00190-1 PubMed DOI |
| 2. | Young-PEARL trial: paradoxical results of overall survival Author: Yin, Wenjin; Zhu, Pinxuan; Lu, Jinsong Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 6, pp. e295-e295. DOI: PubMed |
| 3. | Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study Author: Blondeaux, Eva; Sonnenblick, Amir; Agostinetto, Elisa; Bas, Raphaelle; Kim, Hee J.; Franzoi, Maria A.; Bernstein-Molho, Rinat; Linn, Sabine; Kwong, Ava; Pogoda, Katarzyna; Balmana, Judith; Smeets, Ann; Bajpai, Jyoti; Moore, Halle C. F.; Partridge, Ann H.; Phillips, Kelly-Anne; Toss, Angela; Rousset-Jablonski, Christine; Peccatori, Fedro A.; Renaud, Tiphaine; Ferrari, Alberta; Paluch-Shimon, Shani; Mando, Pablo; Lee, Jeong E.; Fruscio, Robert; Cui, Wanda; Wong, Stephanie M.; Vernieri, Claudio; Ruddy, Kathryn J.; Dieci, Maria, V; Matikas, Alexios; Rozenblit, Mariya; Guven, Deniz C.; Lee, Minna; Villarreal-Garza, Cynthia; Hwang, Shelley E.; De Marchis, Laura; Puglisi, Fabio; Kemp, Zoe; Meireles, Pedro A.; Parokonnaya, Anastasia; Werutsky, Gustavo; Okano, Maiko; Azim Jr, Hatem A.; Mati, Kleida; Rosenberg, Shoshana; Gelber, Richard; Boni, Luca; Lambertini, Matteo Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 6, pp. 759-770. DOI: 10.1016/S1470-2045(25)00152-4 PubMed DOI |
| 4. | Limitations in the meta-analysis of prostate radiotherapy-associated toxicity Author: Liang, Zongjian; Chen, Kun; Sun, Fa Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 5, pp. e233-e233. DOI: PubMed |
| 5. | Re-evaluating anxiety levels and participant characteristics in PATHFINDER Author: Xiang, Ze; Xu, Yunyang; Wu, Jian Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 4, pp. e185-e185. DOI: PubMed |
| 6. | Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis Author: Dee, Edward Christopher; Laversanne, Mathieu; Bhoo-Pathy, Nirmala; Ho, Frances Dominique, V; Feliciano, Erin Jay G.; Eala, Michelle Ann B.; Ting, Frederic Ivan L.; Ginsburg, Ophira; Moraes, Fabio Ynoe; Gyawali, Bishal; Gomez, Scarlett Lin; Ng, Kenrick; Wu, James Fan; Jain, Urvish; Jain, Bhav; Columbres, Rod Carlo; Matsuda, Tomohiro; Sangrajrang, Suleeporn; Sinuraya, Evlina Suzanna; Bui, Tung Duc; Wei, Wenqiang; Won, Young-Joo; Li Foo, Ling; Ling, Mei Chuan Annie; Mery, Les; Soerjomataram, Isabelle; Bray, Freddie Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 4, pp. 516-528. DOI: 10.1016/S1470-2045(25)00017-8 PubMed DOI |
| 7. | Trastuzumab rezetecan, a HER2-directed antibody-drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study Author: Li, Ziming; Wang, Yan; Sun, Yuping; Wang, Linlin; Li, Xingya; Sun, Longhua; He, Zhiyi; Yang, Haiyan; Wang, Yongsheng; Wang, Qiming; Song, Zhengbo; Hong, Wei; Wang, Yong; Xia, Guohao; Yu, Yan; Peng, Min; Song, Yong; Wang, Donglin; Meng, Rui; Fang, Jian; Luo, Yongzhong; Liang, Wenhua; Hu, Sheng; Wang, Zhihui; Song, Ke; Li, You; Yang, Lulu; Shi, Wei; Lu, Shun Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 4, pp. 437-446. DOI: 10.1016/S1470-2045(25)00012-9 PubMed DOI |
| 8. | Aromatase inhibitors, cardiovascular medications, and patient outcomes Author: Luo, Peng; Zhang, Jian; Lin, Anqi Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 2, pp. e74-e74. DOI: PubMed |
| 9. | Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b-2 study Author: Finn, Richard S.; Ryoo, Baek-Yeol; Hsu, Chih-Hung; Li, Daneng; Burgoyne, Adam M.; Cotter, Christopher; Badhrinarayanan, Shreya; Wang, Yulei; Yin, Anqi; Edubilli, Tirupathi Rao; Mahrus, Sami; Secrest, Matthew H.; Shemesh, Colby S.; Yu, Nancy; Hack, Stephen P.; Cha, Edward; Gane, Ed Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 2, pp. 214-226. DOI: 10.1016/-2045(24)00679-X PubMed DOI |
| 10. | De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006) a multicentre, randomised, phase 3 trial Author: Chen, Xiu-Chun; Jiao, De-Chuang; Qiao, Jiang-Hua; Wang, Cheng-Zheng; Sun, Xian-Fu; Lu, Zhen-Duo; Li, Lian-Fang; Zhang, Chong-Jian; Yan, Min; Wei, Ya; Chen, Bo; Feng, Yue-Qing; Deng, Miao; Ma, Ming-De; Plichta, Jennifer K.; He, You-Wen; Liu, Zhen-Zhen Journal: LANCET ONCOLOGY. 2025; Vol. 26, Issue 1, pp. 27-36. DOI: 10.1016/S1470-2045(24)00581-3 PubMed DOI |
|
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
